SCLX Company Profile and Key Details

Scilex Holding Company has 6.96 million shares outstanding. The public float is 2.92 million shares, elevated short interest at 10.80% of float. This equals 447.39 thousand shares. The short ratio is 2.05 days. Institutional investors hold 99.45% of the float. Insiders own 21.43%. Ji Henry holds 320.16 thousand shares, SHAH JAISIM has 139.33 thousand shares and Chun Jay has 112.50 thousand shares.

Short-term trend indicators are bearishly aligned (SMA20 -21.4%, SMA50 -16.9%, SMA200 10.72%). The stock’s 14-day RSI is 33.38 (weak momentum), while the ATR of 1.5 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -58.13% below its high and over 298.61% above its low. Average 10-day trading volume of 74.87 thousand shares is below the 3-month average of 178.89 thousand, indicating normal recent market interest.

Scilex Holding Company generated EPS of -$33.08 over the past year. Five-year average earnings growth is -526.67%. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $22.00 to $18.00. The high target offers 53.31% upside. The low target suggests 25.44% downside. The mean target is $20.67. This offers 44.04% upside. Scilex Holding Company earnings surprise history is a mixed track record. The quarter that ended November 17, 2025, missed forecasts by -31768.14%. The prior quarter beat by -31768.14%. Over the last six quarters, Apple has recorded several small beats. These include 3600.0% in January 17, 2025.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Scilex Holding Company (NASDAQ:SCLX) closed at $14.10 USD, losing -$0.25 (-1.73%) from the previous close of $14.35. The stock is currently mid-range between its 52-week high and low $3.60 and $34.27. With a market capitalization of about $120.45 million, Scilex Holding Company is classified as a micro-cap and shows higher-than-market volatility (beta ~1.34). Key stats such as the average daily volume over the past year has been around 180.48 thousand shares, volume is running light vs its 52-week average. Headquartered in Palo Alto, CA, Scilex Holding Company operates in the Healthcare sector and the Drug Manufacturers - General industry. Led by CEO Henry H. Ji, the company employs approximately 115 people and listed since March 05, 2021. Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain.

Scilex Holding Company trades at a P/E ratio of -0.44, slightly below the S&P 500 average, with a price-to-sales ratio of 3.04 and a price-to-book ratio of -0.93 indicating negative book value, which may reflect financial stress. The P/FCF stands at 5.11, also above market averages.

Our AI price prediction model suggests that Scilex Holding Company stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.53%, with price expected at $13.70 by January 02, 2026, within a range of $11.82 to $15.67 3-Month Outlook: Projected fall of -3.0%, reaching $13.92 by March 19, 2026, with a range of $10.61 to $15.47. 1-Year Outlook: Projected gain of 215.96%, with price at $45.34 by December 18, 2026, within a range of $0.00 to $30.14.

Scilex Holding Company (NASDAQ:SCLX) shares are flat -3.85% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Scilex Holding Company trading at a premium to the broader market with a P/E of -0.44. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $13.33, suggesting -7.11% downside. Our AI forecast model points to short-term weakness (-4.53% over two weeks), a medium-term fall (-3.0% over three months), and a longer-term gain (215.96% over one year), with expected trading ranges indicating moderate volatility.